(Q36821101)

16 August 2017

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. (English)

1 reference

16 August 2017

1 reference

1 reference

1 reference

27

Laurence Zitvogel

0 references

Nathalie Chaput

28

Nathalie Chaput

0 references

Sylvie Rusakiewicz

24

Sylvie Rusakiewicz

0 references

Sophie Viaud

19

Sophie Viaud

0 references

Nadège Vimond

12

Nadège Vimond

0 references

Alexander Eggermont

25

Alexander Eggermont

0 references

Jean-Charles Soria

20

Jean-Charles Soria

0 references

Clotilde Théry

14

Elke Pogge von Strandmann

Clotilde Théry

0 references

22

Elke Pogge von Strandmann

1 reference

16 August 2017

Frédéric Vély

23

0 references

Olivier Lantz

Olivier Lantz

5

0 references

Thierry Le Chevalier

7

Thierry Le Chevalier

1 reference

16 August 2017

Benjamin Besse

1

1 reference

16 August 2017

Mélinda Charrier

2

1 reference

16 August 2017

Valérie Lapierre

3

1 reference

16 August 2017

Eric Dansin

4

1 reference

16 August 2017

David Planchard

6

1 reference

16 August 2017

Alain Livartoski

8

1 reference

16 August 2017

Fabrice Barlesi

9

1 reference

16 August 2017

Agnès Laplanche

10

1 reference

16 August 2017

Stéphanie Ploix

11

1 reference

16 August 2017

Isabelle Peguillet

13

1 reference

16 August 2017

Ludovic Lacroix

15

1 reference

16 August 2017

Inka Zoernig

16

1 reference

16 August 2017

Kavita Dhodapkar

17

1 reference

16 August 2017

Madhav Dhodapkar

18

1 reference

16 August 2017

Katrin S Reiners

21

1 reference

16 August 2017

Jonathan M Pitt

26

1 reference

16 August 2017

12 August 2015

1 reference

16 August 2017

1 reference

16 August 2017

5

1 reference

16 August 2017

4

1 reference

16 August 2017

e1071008

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

16 August 2017

start time

12 August 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Dendritic cell-derived exosomes as immunotherapies in the fight against cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Regulation of immune responses by extracellular vesicles

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Maintenance strategies in stage IV non-small-cell lung cancer (NSCLC): in which patients, with which drugs?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

BAG-6, a jack of all trades in health and disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Oncology meets immunology: the cancer-immunity cycle

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Rescue of impaired NK cell activity in hodgkin lymphoma with bispecific antibodies in vitro and in patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Harnessing the power of the immune system to target cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Dendritic cell-derived exosomes for cancer immunotherapy: what's next?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Sequential interplay between BAG6 and HSP70 upon heat shock

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Reversible inhibition of Hsp70 chaperone function by Scythe and Reaper

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Chaperon and adjuvant activity of hsp70: different natural killer requirement for cross-priming of chaperoned and bystander antigens

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

Production and characterization of clinical grade exosomes derived from dendritic cells.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4839329

ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming

5 September 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2015.1071008

Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2015.1071008

Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2015.1071008

Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2015.1071008

Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27141373

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27141373

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27141373

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/2162402X.2015.1071008

1 reference

16 August 2017

1 reference

16 August 2017

1 reference